Korify Capital

FORME Life is a modular smart home gym and home fitness system for fitness and strength workouts. The company combines advanced linked fitness devices with coaching and personal training provided by real people to provide an immersive experience and improve results for both clients and trainers.

Cambrian Biopharma is a multi-asset biotech R&D firm uniquely focused on a specific field of biomedical research: the biology of aging, also known as geroscience. We believe the future of medicine should be proactive and committed to extending our best years, not just reactive to certain diseases. As experts in the biology of age-related disease, it is our mission to assemble the world's best scientists to accelerate this paradigm shift. We are built on an emerging business model we call a "Distributed R&D Company" (or "DisCo"), partnering with academic geroscientists to build companies, conduct preclinical drug discovery, and manage clinical trials. Cambrian looks to discover and develop therapeutics that target the molecular damage that arises during aging and leads to chronic disease. Our approach is to build a diverse portfolio led by scientific rigor and data, not ego. Focusing on early-stage therapeutics, we collaborate with pioneering scientists to bring discoveries out of the lab and into the clinic as efficiently as possible. So far, we have launched 10 companies with leading geroscientists and have relationships with more than 100 geroscience-focused labs globally, translating to a toolkit for tech-transfer negotiations and rapid spinouts.

Olsam Group is a technology-driven commerce company that acquires and operates top Amazon third-party and other D2C eCommerce brands at scale.

Wonder Brands is a Latin American startup specialized in partnering with successful digital brands to boost their growth. The implementation of its strategy is achieved by injecting into associated companies a significant investment to exponentially increase working capital, marketing and equipment, as well as providing added value in the areas of technology, digital marketing, supply chain and administration.

Bullish Global is a new blockchain-based cryptocurrency exchange designed to combine the performance, user privacy, and compliance offered by central order book technology with the vertically integrated user benefits of decentralized finance (DeFi) market architecture.

Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.

Atai Life Sciences is a biotechnology company that develops therapies for mental health disorders. The company focuses on creating treatments using psychedelic compounds and other methods to address conditions such as depression, anxiety, and substance use disorders. Atai collaborates with various partners and research institutions to advance its drug development pipeline, which includes several clinical-stage programs. The product portfolio includes therapies that utilize research in psychedelics and neuroscience. Atai's lead programs feature ketamine-based treatments and other compounds aimed at improving mental well-being. The company works with experts in the field to ensure the efficacy and safety of its therapies. Atai Life Sciences has received recognition for its work in mental health treatment, securing partnerships and funding to support its research initiatives. The company has been acknowledged for its contributions to psychiatry and has gained attention for its efforts to advance the understanding and treatment of mental health disorders.

Nextmarkets is dedicated to `helps private investors to operate in a sustainable and better educated manner on the stock exchange. For this purpose, the company developed a very easy-to-use trading platform in which private investors can trade more than 1,000 CFDs on equities , foreign exchange ( forex , FX ), bonds and commodities very intuitively - via web and mobile apps . It is scientifically proven that more than 80 percent of all private investors fail on the stock market . This has predominantly behavioral economic reasons.

Cambrian Biopharma is a multi-asset biotech R&D firm uniquely focused on a specific field of biomedical research: the biology of aging, also known as geroscience. We believe the future of medicine should be proactive and committed to extending our best years, not just reactive to certain diseases. As experts in the biology of age-related disease, it is our mission to assemble the world's best scientists to accelerate this paradigm shift. We are built on an emerging business model we call a "Distributed R&D Company" (or "DisCo"), partnering with academic geroscientists to build companies, conduct preclinical drug discovery, and manage clinical trials. Cambrian looks to discover and develop therapeutics that target the molecular damage that arises during aging and leads to chronic disease. Our approach is to build a diverse portfolio led by scientific rigor and data, not ego. Focusing on early-stage therapeutics, we collaborate with pioneering scientists to bring discoveries out of the lab and into the clinic as efficiently as possible. So far, we have launched 10 companies with leading geroscientists and have relationships with more than 100 geroscience-focused labs globally, translating to a toolkit for tech-transfer negotiations and rapid spinouts.

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies. The company developing novel biologics therapies targeting key components of the immune system for the treatment of cancers of unmet need. They are also focused on the discovery, development, and delivery of medicines that alter the treatment landscape and contributing value to patients and society. Sensei Biotherapeutics using its proprietary drug discovery platform to study and understand the tumor microenvironment and identify a new class of cancer immunotherapies that act through new biology and differentiated mechanisms. It brings together scientific leaders in biology, immunology, and oncology along with a highly experienced management team and scientific advisors. The company's platform, ImmunoPhage enables the generation of immune-activating agents that fully engage activation of both the innate and adaptive immune systems. Sensei Biotherapeutics is headquartered in Gaithersburg, Maryland with an office in Boston, MA, USA.

Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.

Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.

Atai Life Sciences is a biotechnology company that develops therapies for mental health disorders. The company focuses on creating treatments using psychedelic compounds and other methods to address conditions such as depression, anxiety, and substance use disorders. Atai collaborates with various partners and research institutions to advance its drug development pipeline, which includes several clinical-stage programs. The product portfolio includes therapies that utilize research in psychedelics and neuroscience. Atai's lead programs feature ketamine-based treatments and other compounds aimed at improving mental well-being. The company works with experts in the field to ensure the efficacy and safety of its therapies. Atai Life Sciences has received recognition for its work in mental health treatment, securing partnerships and funding to support its research initiatives. The company has been acknowledged for its contributions to psychiatry and has gained attention for its efforts to advance the understanding and treatment of mental health disorders.